Table Of ContentJOURNOAF LTH E
NEUROLOGICAL
SCIENCES
Journal of the Neurological Sciences 140 (1996) 143-144
Author Index (Vol. 140)
Abe, Y., Doi, K., Katoh, Y., Yamamoto, H., Kataoka, H. and Kawai, S. Hoffman, E.P., see Duggan, D.J. (140) 30
The limit of low speed peripheral nerve elongation; neurological and Horstink, M.W.I.M., see Praamstra, P. (140) 67
circulatory aspects (140) 61 Huygen, P.L.M., see Verhagen, W.I.M. (140) 85
Aii, H., see Katsumi, Y. (140) 46
Alder, H., see Kalman, B. (140) 75
Angelini, C., see Duggan, D.J. (140) 30 Inagaki, T., see Ono, S. (140) 96
Anichini, M., see Malandrini, A. (140) 129
Arts, W.F.M., see Verhagen, W.I.M. (140) 85
Jeng, J.-S., see Liou, H.-H. (140) 53
Jinnai, K., see Ono, S. (140) 96
Biessels, G.J., Stevens, E.J., Mahmood, S.J., Gispen, W.H. and Tomlin- Jénsdéttir, S., see Sveinbjérnsdéttir, S. (140) 101
son, D.R.
Insulin partially reverses deficits in peripheral nerve blood flow and
conduction in experimental diabetes (140) 12
Kalman, B., Lublin, F.D. and Alder, H.
Bignotti, V., see Prelle, A. (140) 132
Characterization of the mitochondrial DNA in patients with multiple
Blaauwgeers, H.G.T., De Jong, J.M.B.V., Verspaget, H.W., Van den sclerosis (140) 75
Berg, F.M. and Troost, D. Kanazawa, I., see Hanajima, R. (140) 109
Enhanced superoxide dismutase-2 immunoreactivity of astrocytes and Kanda, F., see Ono, S. (140) 96
occasional neurons in amyotrophic lateral sclerosis (140) 21 Kataoka, H., see Abe, Y. (140) 61
Bléndal, H., see Sveinbjérnsdéttir, S. (140) 101 Katoh, Y., see Abe, Y. (140) 61
Bradley, W.G., see Romano, J.G. (140) 137
Katsumi, Y., Fukuyama, H., Ogawa, M., Matsui, M., Tokonami, F., Aii,
H., Sugie, H., Murakami, N. and Nonaka, I.
Cesaretti, S., see Malandrini, A. (140) 129 Cerebral oxygen and glucose metabolism in glycogen storage disease
Chang, Y.-C., see Liou, H.-H. (140) 53 with normal acid maltase: case report (140) 46
Chen, R.-C., see Liou, H.-H. (140) 53 Kawabata, T., see Nishimura, M. (140) 91
Ciscato, P., see Prelle, A. (140) 132 Kawai, S., see Abe, Y. (140) 61
Collan, Y., see Ma, S.Y. (140) 40 Kim, J.S.
Comi, G.P., see Prelle, A. (140) 132 Bilateral perioral sensory symptom after unilateral stroke: Does it
Cools, A.R., see Praamstra, P. (140) 67 have a localizing value? (140) 123
Kjartansson, O., see Sveinbjérnsdéttir, S. (140) 101
Kurisaki, H., see Ono, S. (140) 96
De Jong, J.M.B.V., see Blaauwgeers, H.G.T. (140) 21
Kuroki, S., see Nishimura, M. (140) 91
Doi, K., see Abe, Y. (140) 61
Duggan, D.J., Fanin, M., Pegoraro, E., Angelini, C. and Hoffman, E.P.
a-Sarcoglycan (adhalin) deficiency: complete deficiency patients are
Liou, H.-H., Jeng, J.-S., Chang, Y.-C., Chen, R.-C. and Yip, P.-K.
5% of childhood-onset dystrophin-normal muscular dystrophy and Is ataxic gait the predominant presenting manifestation of Creutzfeldt.
most partial deficiency patients do not have gene mutations (140) 30
-Jakob disease? Experience of 14 Chinese cases from Taiwan (140)
53
Fabrizi, G.M., see Malandrini, A. (140) 129 Lublin, F.D., see Kalman, B. (140) 75
Fagiolari, G., see Prelle, A. (140) 132
Fanin, M., see Duggan, D.J. (140) 30
Fisher, M., see Tatlisumak, T. (140) | Ma, S.Y., Rinne, J.O., Collan, Y., R6ytté, M. and Rinne, U.K.
Fukuoka, Y., see Ono, S. (140) 96 A quantitative morphometrical study of neuron degeneration in the
Fukuyama, H., see Katsumi, Y. (140) 46 substantia nigra in Parkinson’s disease (140) 40
Mahmood, S.J., see Biessels, G.J. (140) 12
Malandrini, A., Cesaretti, S., Mulinari, M., Palmeri, S., Fabrizi, G.M.,
Gispen, W.H., see Biessels, G.J. (140) 12
Villanova, M., Parrotta, E., Montagnani, A., Montagnani, M., Ani-
Green, B., see Romano, J.G. (140) 137
chini, M. and Guazzi, G.C.
Guazzi, G.C., see Malandrini, A. (140) 129
Acanthocytosis, retinitis pigmentosa, pallidal degeneration. Report of
Gudmundsson, G., see Sveinbjérnsdéttir, S. (140) 101
two cases without serum lipid abnormalities (140) 129
Gudmundsson, G., see Sveinbjérnsdéttir, S. (140) 101
Matsui, M., see Katsumi, Y. (140) 46
Mitake, S., see Ono, S. (140) 96
Hanajima, R., Ugawa, Y., Terao, Y., Ogata, K. and Kanazawa, I. Moggio, M., see Prelle, A. (140) 132
Ipsilateral cortico-cortical inhibition of the motor cortex in various Montagnani, A., see Malandrini, A. (140) 129
neurological disorders (140) 109 Montagnani, M., see Malandrini, A. (140) 129
144 Author Index (Vol. 143)
Mulinari, M., see Malandrini, A. (140) 129 Saida, K., see Nishimura, M. (140) 91
Murakami, N., see Katsumi, Y. (140) 46 Saida, T., see Nishimura, M. (140) 91
Scarlato, G., see Prelle, A. (140) 132
Nagao, K., see Ono, S. (140) 96 Schorr, M., Zhou, L. and Schwechheimer, K.
Nishimura, M., Saida, T., Kuroki, S., Kawabata, T., Obayashi, H., Saida, Expression of ciliary neurotrophic factor is maintained in spinal motor
K. and Uchiyama, T. neurons of amyotrophic lateral sclerosis (140) 117
Post-infectious encephalitis with anti-galactocerebroside antibody sub- Schwechheimer, K., see Schorr, M. (140) 117
sequent to Mycoplasma pneumoniae infection (140) 91 Sciacco, M., see Prelle, A. (140) 132
Nonaka, I., see Katsumi, Y. (140) 46 Stegeman, D.F., see Praamstra, P. (140) 67
Stevens, E.J., see Biessels, G.J. (140) 12
Obayashi, H., see Nishimura, M. (140) 91 Sugie, H., see Katsumi, Y. (140) 46
Ogata, K., see Hanajima, R. (140) 109 Sveinbjérnsdéttir, S., Bléndal, H., Gudmundsson, G., Kjartansson, 6..,
Ogawa, M., see Katsumi, Y. (140) 46 Jénsdéttir, S. and Gudmundsson, G.
Ono, S., Takahashi, K., Kanda, F., Fukuoka, Y., Jinnai, K., Kurisaki, H., Progressive dementia and leucoencephalopathy as the initial presenta-
Mitake, S., Inagaki, T. and Nagao, K. tion of late onset hereditary cystatin-C amyloidosis. Clinicopathologi-
Immunohistochemical study of intracytoplasmic inclusion bodies of cal presentation of two cases (140) 101
the thalamus in myotonic dystrophy (140) 96
Takahashi, K., see Ono, S. (140) 96
Palmeri, S., see Malandrini, A. (140) 129 Tatlisumak, T. and Fisher, M.
Park-Matsumoto, Y.C. and Tazawa, T. Hematologic disorders associated with ischemic stroke (140) 1
Piperacillin-induced encephalopathy (140) 141 Tazawa, T., see Park-Matsumoto, Y.C. (140) 141
Parrotta, E., see Malandrini, A. (140) 129 Terao, Y., see Hanajima, R. (140) 109
Pegoraro, E., see Duggan, D.J. (140) 30 Tokonami, F., see Katsumi, Y. (140) 46
Praamstra, P., Cools, A.R., Stegeman, D.F. and Horstink, M.W.I.M. Tomlinson, D.R., see Biessels, G.J. (140) 12
Movement-related potential measures of different modes of move- Troost, D., see Blaauwgeers, H.G.T. (140) 21
ment selection in Parkinson's disease (140) 67
Prelle, A., Rigoletto, C., Moggio, M., Sciacco, M., Comi, G.P., Ciscato, Uchiyama, T., see Nishimura, M. (140) 91
P., Fagiolari, G., Rapuzzi, S., Bignotti, V. and Scarlato, G. Ugawa, Y., see Hanajima, R. (140) 109
Asymptomatic familial hyperCKemia associated with desmin accumu-
lation in skeletal muscle (140) 132 Van den Berg, F.M., see Blaauwgeers, H.G.T. (140) 21
Verhagen, W.I.M., Huygen, P.L.M. and Arts, W.F.M.
Rapuzzi, S., see Prelle, A. (140) 132 Multi-system signs and symptoms in X-linked ataxia carriers (140) 85
Rigoletto, C., see Prelle, A. (140) 132 Verspaget, H.W., see Blaauwgeers, H.G.T. (140) 21
Rinne, J.0., see Ma, S.Y. (140) 40 Villanova, M., see Malandrini, A. (140) 129
Rinne, U.K., see Ma, S.Y. (140) 40
Romano, J.G., Bradley, W.G. and Green, B. Yamamoto, H., see Abe, Y. (140) 61
High cervical myelopathy presenting with the numb clumsy hand Yip, P.-K., see Liou, H.-H. (140) 53
syndrome (140) 137
Réytt, M., see Ma, S.Y. (140) 40 Zhou, L., see Schorr, M. (140) 117
JOURNOAF LTH E
NEUROLOGICAL
SCIENCES
Journal of the Neurological Sciences 140 (1996) 145-146
Subject Index (Vol. 140)
Acanthocytosis, (140) 129 Immunohistochemistry, (140) 21, (140) 96
Acute disseminated encephalomyelitis (ADEM), (140) 91 Immunoreaction, (140) 117
Adhalin, (140) 30 Inhibition, (140) 109
ALS, (140) 117 Insulin, (140) 12
Amyloid, (140) 101 Interneuron, (140) 109
Angiopathy, (140) 101 Intracytoplasmic inclusion body, (140) 96
Anticoagulant, (140) 1 Ischemic stroke, (140) 1
Antiphospholipid, (140) 1
a-sarcoglycan, (140) 30
Laser Doppler flowmetry, (140) 12
Ataxic gait, (140) 53
Limb lengthening, (140) 61
Lipoprotein, (140) 129
Basal ganglia, (140) 109
Bilateral, (140) 123
Brain stem auditory evoked potential, (140) 85 Magnetic stimulation, (140) 109
Manifesting heterozygote, (140) 85
Membrane cytoskeleton, (140) 30
Cardiomyopathy, (140) 46
Mental retardation, (140) 46
Cell size, (140) 40
Motor cortex, (140) 67, (140) 109
Cerebral hemorrhages, (140) 101
Movement preparation, (140) 67
Cerebral lesion, (140) 123
Movement-related potentials, (140) 67
Cerebrovascular disorder, (140) 123
Multiple sclerosis, (140) 75
Chinese from Taiwan, (140) 53
Muscular dystrophy, (140) 30
CNTF, (140) 117
Mycoplasma pneumoniae, (140) 91
Coagulation, (140) 1
Myotonic dystrophy, (140) 96
Creutzfeldt-Jakob disease, (140) 53
Dementia, (140) 101 Nerve blood flow, (140) 12, (140) 61
Desmin, (140) 132 Nerve conduction, (140) 12
Desminopathy, (140) 132 Nerve elongation, (140) 61
Diabetic neuropathy, (140) 12 Neuromorphometry, (140) 40
mtDNA variant, (140) 75 Neuron, (140) 117
Dystrophin, (140) 30 Neuropathology, (140) 40
Encephalopathy, (140) 141 Parkinson’s disease, (140) 40, (140) 67
Enzyme-linked immunosorbent assay, (140) 21 Penicillin, (140) 141
Experimental allergic neuritis (EAN), (140) 91 Perioral, (140) 123
External fixator, (140) 61 Peripheral nerve, (140) 61
Piperacillin, (140) 141
Plasma exchange, (140) 91
Familial amyotrophic lateral sclerosis, (140) 21
Positron emission tomography, (140) 46
Free radical, (140) 21
Post-infectious encephalitis, (140) 91
Prion, (140) 53
Galactocerebroside, (140) 91 Proximal myopathy, (140) 46
Genetic susceptibility, (140) 75
Glia, (140) 21
Glycogen storage disease with normal acid maltase, (140) 46 Rabbit, (140) 61
Readiness potential, (140) 67
Hallervorden-Spatz disease, (140) 129
HARP-syndrome, (140) 129 Saccades, (140) 85
HCCA, (140) 101 Sensation, (140) 123
HCHWA, (140) 101 Sensorineural hearing loss, (140) 85
Heparin, (140) 1 Smooth pursuit eye movement, (140) 85
Hereditary, (140) 101 Speech discrimination, (140) 85
HyperCKemia, (140) 132 Sporadic amyotrophic lateral sclerosis, (140) 21
Hypercoagulable state, (140) 1 Streptozotocin-diabetes, (140) 12
146 Subject Index (Vol. 140)
Substantia nigra, (140) 40 Ubiquitin, (140) 96
Superoxide dismutases | and 2, (140) 21
Supplementary motor area, (140) 67 Vestibular system, (140) 85
Thalamic inclusion, (140) 96 Warfarin, (140) 1
Thrombosis, (140) 1 Western blot, (140) 117
' o “
- x,
A t.
? A i 7 ia t :
* : - : -
. cal;
oy - & rs
a. . x
: a
ea :
5 Bi .
‘: , ’ . : i
o ¢ {
